Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Recent studies in rodents show that glucagon-like peptide-1 (GLP-1) analogues protect against
diabetic nephropathy. We hypothesise that this is also the case in humans. This study will
investigate the short-term effect of liraglutide (GLP-1 analogue) on the kidneys in type 2
diabetic patients. Impact on basic kidney physiological will be determined and kidney injury
markers will be measured as surrogate parameters of kidney protection.